021-51111890
购物车（）
sales@molnova.cn
Dammarenediol II
CAS No. 14351-29-2
Dammarenediol II ( —— )
产品货号. M30869 CAS No. 14351-29-2
Dammarenediol II may have the ability to prevent diabetic microvascular complications, including diabetic retinopathy.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥4066 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Dammarenediol II
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Dammarenediol II may have the ability to prevent diabetic microvascular complications, including diabetic retinopathy.
-
产品描述Dammarenediol II may have the ability to prevent diabetic microvascular complications, including diabetic retinopathy, it can inhibit vascular endothelial growth factor (VEGF)-induced intracellular reactive oxygen species generation and stress fiber formation and vascular endothelial-cadherin disruption. The medicinally important dammarenediol II can be ectopically produced in tobacco, and the production of dammarenediol-II in tobacco plants allows them to adopt a viral defense system.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number14351-29-2
-
分子量444.7
-
分子式C30H52O2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 50 mg/mL (112.43 mM)
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
[Pro3]-GIP (Mouse)
GIP receptor antagonist (IC50 = 2.6μM). Inhibits GIP-stimulated insulin release from pancreatic β cells in vitro. In ob/ob mice, blocks the effects of GIP on insulin release and plasma glucose levels. Also improves intraperitoneal glucose tolerance, insulin sensitivity, and glucose response to feeding in ob/ob mice.
-
Interleukin-1β Conve...
Interleukin-1β Convertase Substrate
-
Safflospermidine B
Safflospermidine B is a potential natural tyrosinase inhibitor, it shows high antityrosinase activity (IC50 of 31.8μM).
